Open AccessDrug survival rate of dupilumab in Japanese patients with atopic dermatitis
Author(s) -
Ichiyama Susumu,
Ito Michiko,
Hoashi Toshihiko,
Kanda Naoko,
Saeki Hidehisa
Publication year - 2021
Publication title -
journal of cutaneous immunology and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.127
H-Index - 1
ISSN - 2574-4593
DOI - 10.1002/cia2.12188
Subject(s) - dupilumab , atopic dermatitis , medicine , dermatology
We investigated the drug survival rate of dupilumab for Japanese atopic dermatitis patients and predictive parameters of the survival. Eight of the 58 patients discontinued dupilumab during the 12 months and the overall probability of dupilumab survival at 12 months was 86.2%. Patients who continued dupilumab were older than that of those who discontinued it and the disease duration of those who continued was longer than that of those who discontinued.